fluorocholine Report issue

Small molecule Imaging Experimental
AACT MeSH PubChem

Active Ingredient History

NOW
  • Now
18F-Fluorocholine is an oncologic PET tracer.   Wikipedia

Chemistry

More Chemistry

Pharmacology

  • Mechanism of Action:
  • Multi-specific: Missing data
  • Imaging: 18-fluoride
  • Black Box: Missing data
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: Missing data

Alternative names

18f-fch | 18f fluorocholine | 18f-fluorocholine | f18 fluorocholine | fluorocholine | n,n-dimethyl-n-(18f)fluoromethyl-2-hydroxyethylammonium

Organizations (19)

Research & Development (19)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (12)

Approved Indications (1)


 

Prostatic Diseases

Experimental Indications - Clinical Trial Phases 1-4 (11)


 

Breast Neoplasms (Phase 4)

Carcinoma, Hepatocellular (Phase 3)

Choline (Phase 3)

Hyperparathyroidism, Primary (Phase 3)

Liver Diseases (Phase 3)

Magnetic Resonance Imaging (Phase 4)

Multiple Myeloma (Phase 3)

Parathyroid Diseases (Phase 3)

Positron-Emission Tomography (Phase 4)

Positron Emission Tomography Computed Tomography (Phase 3)

Prostatic Neoplasms (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 16
  • # of Trial Organizations: 19

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue